October 11, 2018 (Noon – 1 p.m.)
Sponsor/Co-Sponsor(s)
Pregnancy and Perinatology Branch (PPB), Division of Extramural Research (DER), NICHD
Location
6710B Rockledge Drive, Room 1417, Bethesda, MD
Purpose
Oligo/anhydramnios, or low or absent amniotic fluid, can cause stillbirth, fetal skeletal abnormalities, and pulmonary hypoplasia. These problems occur along with major fetal renal malformations, including absent kidneys.
Instead of traditional palliative therapy, new approaches are evolving. Tonse Raju, M.D., D.C.H., PPB Chief, will address the following questions:
- What are the new therapies for women with anhydramnios?
- How do we treat newborn infants who have no kidney?
- What are the risks/benefits and long-term outcomes?
- What are the ethical challenges?
Contact
Reon Holloway, PPB, NICHD